These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9343036)

  • 1. Ticlopidine-carbamazepine interaction in a coronary stent patient.
    Brown RI; Cooper TG
    Can J Cardiol; 1997 Sep; 13(9):853-4. PubMed ID: 9343036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
    Calver AL; Blows LJ; Harmer S; Dawkins KD; Gray HH; Morgan JH; Simpson IA
    Am Heart J; 2000 Sep; 140(3):483-91. PubMed ID: 10966552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
    Wolak A; Amit G; Cafri C; Gilutz H; Ilia R; Zahger D
    Int J Cardiol; 2005 Sep; 103(3):293-7. PubMed ID: 16098392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic therapy after coronary-artery stenting.
    Ferrer F; Moraleda JM; Vicente V
    N Engl J Med; 1999 Apr; 340(17):1365; author reply 1367. PubMed ID: 10223873
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiplatelet and anticoagulant therapy after coronary-artery stenting.
    Schöneberger AA; Schmidt K
    N Engl J Med; 1996 Oct; 335(15):1160; author reply 1161. PubMed ID: 8848025
    [No Abstract]   [Full Text] [Related]  

  • 6. Case report on clopidogrel rash after coronary placement of a paclitaxol-coated stent.
    Satish B; Tressa K; Harish CR
    Crit Pathw Cardiol; 2007 Mar; 6(1):24-5. PubMed ID: 17667883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rash with both clopidogrel and ticlopidine in two patients following percutaneous coronary intervention with drug-eluting stents.
    Makkar K; Wilensky RL; Julien MB; Herrmann HC; Spinler SA
    Ann Pharmacother; 2006 Jun; 40(6):1204-7. PubMed ID: 16684808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of ischemic heart disease with the platelet aggregation inhibitor clopidogrel].
    Helø OH; Madsen JK; Kastrup J
    Ugeskr Laeger; 2004 Apr; 166(18):1659-62. PubMed ID: 15174400
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation.
    Geisler T; Anders N; Paterok M; Langer H; Stellos K; Lindemann S; Herdeg C; May AE; Gawaz M
    Diabetes Care; 2007 Feb; 30(2):372-4. PubMed ID: 17259513
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving outcomes with antiplatelet therapies in percutaneous coronary intervention and stenting.
    Hobson A; Curzen N
    Thromb Haemost; 2009 Jan; 101(1):23-30. PubMed ID: 19132185
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of ticlopidine monotherapy versus ticlopidine and aspirin after coronary artery stenting: follow-up results of a randomized study.
    Machraoui A; Germing A; Lindstaedt M; von Dryander S; Bojara W; Lawo T; Lemke B; Jaeger D; Grewe P; Deneke T; Barmeyer J
    J Invasive Cardiol; 2001 Jun; 13(6):431-6. PubMed ID: 11385163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.
    Orford JL; Fasseas P; Melby S; Burger K; Steinhubl SR; Holmes DR; Berger PB
    Am Heart J; 2004 Mar; 147(3):463-7. PubMed ID: 14999195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiac effects of carbamazepine therapy].
    Checchini M; Magni M; Scaglione M; Vaccarella A
    Minerva Cardioangiol; 1995 Sep; 43(9):379-81. PubMed ID: 8552266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible ticlopidine-induced cholestatic jaundice.
    Wengrower D
    Am Fam Physician; 2000 Sep; 62(6):1258, 1262. PubMed ID: 11011856
    [No Abstract]   [Full Text] [Related]  

  • 15. A very late stent thrombosis in a patient with diabetes: a call for lifelong dual anti-platelet therapy.
    Pecot CV; Fuller M; Muldowney JA; Misra S
    Tenn Med; 2009 May; 102(5):37-9. PubMed ID: 19456028
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after coronary stent implantation.
    Juergens CP; Wong AM; Leung DY; Lowe HC; Lo S; Fernandes C; Newland EF; Hopkins AP
    Am Heart J; 2004 Apr; 147(4):E15. PubMed ID: 15077098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ticlopidine vs. clopidogrel in addition to aspirin after paclitaxel-eluting stent implantation: insights from the TRUE (Taxusin Real-life Usage Evaluation) Study.
    Biondi-Zoccai GG; Agostoni P; Sangiorgi GM; Iakovou I; Antoniucci D; Grube E; Tamburino C; Di Mario C; Reimers B; Michev I; Goktekin O; Airoldi F; Chieffo A; Cosgrave J; Tassanawiwat W; Colombo A;
    Int J Cardiol; 2006 Apr; 108(3):406-7. PubMed ID: 16520130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in post stenting medication protocol.
    Morice MC
    J Invasive Cardiol; 1995; 7 Suppl A():32A-35A. PubMed ID: 10155114
    [No Abstract]   [Full Text] [Related]  

  • 19. Neutropenia with ticlopidine plus aspirin.
    Haushofer A; Halbmayer WM; Prachar H
    Lancet; 1997 Feb; 349(9050):474-5. PubMed ID: 9040584
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosis.
    Wenaweser P; Windecker S; Billinger M; Cook S; Togni M; Meier B; Haeberli A; Hess OM
    Am J Cardiol; 2007 Feb; 99(3):353-6. PubMed ID: 17261397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.